 | • レポートコード：MRC2-11QY07001 • 出版社/出版日：QYResearch / 2020年11月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、114ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療、製薬 |
| Single User | ￥585,000 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥877,500 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,170,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料は成長/分化因子8のグローバル市場について調査・分析したレポートです。種類別（OSX-200、SRK-015、ACE-2494、ACE-2798、BMS-986089、その他）市場規模、用途別（ベッカー筋ジストロフィー、線維症、骨髄線維症、鎌状赤血球症、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別成長/分化因子8の競争状況、市場シェア ・世界の成長/分化因子8市場：種類別市場規模 2015年-2020年（OSX-200、SRK-015、ACE-2494、ACE-2798、BMS-986089、その他） ・世界の成長/分化因子8市場：種類別市場規模予測 2021年-2026年（OSX-200、SRK-015、ACE-2494、ACE-2798、BMS-986089、その他） ・世界の成長/分化因子8市場：用途別市場規模 2015年-2020年（ベッカー筋ジストロフィー、線維症、骨髄線維症、鎌状赤血球症、その他） ・世界の成長/分化因子8市場：用途別市場規模予測 2021年-2026年（ベッカー筋ジストロフィー、線維症、骨髄線維症、鎌状赤血球症、その他） ・北米の成長/分化因子8市場分析：米国、カナダ ・ヨーロッパの成長/分化因子8市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアの成長/分化因子8市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米の成長/分化因子8市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカの成長/分化因子8市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Acceleron Pharma, Inc.、Atara Biotherapeutics, Inc.、Bristol-Myers Squibb Company、Eli Lilly and Company、Milo Biotechnology LLC、Pfizer Inc.、Regeneron Pharmaceuticals, Inc.、Sarepta Therapeutics, Inc.、Scholar Rock, Inc. ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Market Analysis and Insights: Global Growth/Differentiation Factor 8 Market
The global Growth/Differentiation Factor 8 market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global Growth/Differentiation Factor 8 Scope and Market Size
Growth/Differentiation Factor 8 market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Growth/Differentiation Factor 8 market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Growth/Differentiation Factor 8 market is segmented into
OSX-200
SRK-015
ACE-2494
ACE-2798
BMS-986089
Others
Segment by Application, the Growth/Differentiation Factor 8 market is segmented into
Becker Muscular Dystrophy
Fibrosis
Myelofibrosis
Sickle Cell Disease
Others
Regional and Country-level Analysis
The Growth/Differentiation Factor 8 market is analysed and market size information is provided by regions (countries).
The key regions covered in the Growth/Differentiation Factor 8 market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Growth/Differentiation Factor 8 Market Share Analysis
Growth/Differentiation Factor 8 market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Growth/Differentiation Factor 8 business, the date to enter into the Growth/Differentiation Factor 8 market, Growth/Differentiation Factor 8 product introduction, recent developments, etc.
The major vendors covered:
Acceleron Pharma, Inc.
Atara Biotherapeutics, Inc.
Bristol-Myers Squibb Company
Eli Lilly and Company
Milo Biotechnology LLC
Pfizer Inc.
Regeneron Pharmaceuticals, Inc.
Sarepta Therapeutics, Inc.
Scholar Rock, Inc.
1 Study Coverage
1.1 Growth/Differentiation Factor 8 Product Introduction
1.2 Market Segments
1.3 Key Growth/Differentiation Factor 8 Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Growth/Differentiation Factor 8 Market Size Growth Rate by Type
1.4.2 OSX-200
1.4.3 SRK-015
1.4.4 ACE-2494
1.4.5 ACE-2798
1.4.6 BMS-986089
1.4.7 Others
1.5 Market by Application
1.5.1 Global Growth/Differentiation Factor 8 Market Size Growth Rate by Application
1.5.2 Becker Muscular Dystrophy
1.5.3 Fibrosis
1.5.4 Myelofibrosis
1.5.5 Sickle Cell Disease
1.5.6 Others
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Growth/Differentiation Factor 8 Market Size, Estimates and Forecasts
2.1.1 Global Growth/Differentiation Factor 8 Revenue 2015-2026
2.1.2 Global Growth/Differentiation Factor 8 Sales 2015-2026
2.2 Global Growth/Differentiation Factor 8, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.2.1 Global Growth/Differentiation Factor 8 Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Growth/Differentiation Factor 8 Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global Growth/Differentiation Factor 8 Competitor Landscape by Players
3.1 Growth/Differentiation Factor 8 Sales by Manufacturers
3.1.1 Growth/Differentiation Factor 8 Sales by Manufacturers (2015-2020)
3.1.2 Growth/Differentiation Factor 8 Sales Market Share by Manufacturers (2015-2020)
3.2 Growth/Differentiation Factor 8 Revenue by Manufacturers
3.2.1 Growth/Differentiation Factor 8 Revenue by Manufacturers (2015-2020)
3.2.2 Growth/Differentiation Factor 8 Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Growth/Differentiation Factor 8 Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Growth/Differentiation Factor 8 Revenue in 2019
3.2.5 Global Growth/Differentiation Factor 8 Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Growth/Differentiation Factor 8 Price by Manufacturers
3.4 Growth/Differentiation Factor 8 Manufacturing Base Distribution, Product Types
3.4.1 Growth/Differentiation Factor 8 Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Growth/Differentiation Factor 8 Product Type
3.4.3 Date of International Manufacturers Enter into Growth/Differentiation Factor 8 Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Growth/Differentiation Factor 8 Market Size by Type (2015-2020)
4.1.1 Global Growth/Differentiation Factor 8 Sales by Type (2015-2020)
4.1.2 Global Growth/Differentiation Factor 8 Revenue by Type (2015-2020)
4.1.3 Growth/Differentiation Factor 8 Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Growth/Differentiation Factor 8 Market Size Forecast by Type (2021-2026)
4.2.1 Global Growth/Differentiation Factor 8 Sales Forecast by Type (2021-2026)
4.2.2 Global Growth/Differentiation Factor 8 Revenue Forecast by Type (2021-2026)
4.2.3 Growth/Differentiation Factor 8 Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Growth/Differentiation Factor 8 Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
5.1 Global Growth/Differentiation Factor 8 Market Size by Application (2015-2020)
5.1.1 Global Growth/Differentiation Factor 8 Sales by Application (2015-2020)
5.1.2 Global Growth/Differentiation Factor 8 Revenue by Application (2015-2020)
5.1.3 Growth/Differentiation Factor 8 Price by Application (2015-2020)
5.2 Growth/Differentiation Factor 8 Market Size Forecast by Application (2021-2026)
5.2.1 Global Growth/Differentiation Factor 8 Sales Forecast by Application (2021-2026)
5.2.2 Global Growth/Differentiation Factor 8 Revenue Forecast by Application (2021-2026)
5.2.3 Global Growth/Differentiation Factor 8 Price Forecast by Application (2021-2026)
6 North America
6.1 North America Growth/Differentiation Factor 8 by Country
6.1.1 North America Growth/Differentiation Factor 8 Sales by Country
6.1.2 North America Growth/Differentiation Factor 8 Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Growth/Differentiation Factor 8 Market Facts & Figures by Type
6.3 North America Growth/Differentiation Factor 8 Market Facts & Figures by Application
7 Europe
7.1 Europe Growth/Differentiation Factor 8 by Country
7.1.1 Europe Growth/Differentiation Factor 8 Sales by Country
7.1.2 Europe Growth/Differentiation Factor 8 Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Growth/Differentiation Factor 8 Market Facts & Figures by Type
7.3 Europe Growth/Differentiation Factor 8 Market Facts & Figures by Application
8 Asia Pacific
8.1 Asia Pacific Growth/Differentiation Factor 8 by Region
8.1.1 Asia Pacific Growth/Differentiation Factor 8 Sales by Region
8.1.2 Asia Pacific Growth/Differentiation Factor 8 Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Growth/Differentiation Factor 8 Market Facts & Figures by Type
8.3 Asia Pacific Growth/Differentiation Factor 8 Market Facts & Figures by Application
9 Latin America
9.1 Latin America Growth/Differentiation Factor 8 by Country
9.1.1 Latin America Growth/Differentiation Factor 8 Sales by Country
9.1.2 Latin America Growth/Differentiation Factor 8 Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Growth/Differentiation Factor 8 Market Facts & Figures by Type
9.3 Central & South America Growth/Differentiation Factor 8 Market Facts & Figures by Application
10 Middle East and Africa
10.1 Middle East and Africa Growth/Differentiation Factor 8 by Country
10.1.1 Middle East and Africa Growth/Differentiation Factor 8 Sales by Country
10.1.2 Middle East and Africa Growth/Differentiation Factor 8 Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Growth/Differentiation Factor 8 Market Facts & Figures by Type
10.3 Middle East and Africa Growth/Differentiation Factor 8 Market Facts & Figures by Application
11 Company Profiles
11.1 Acceleron Pharma, Inc.
11.1.1 Acceleron Pharma, Inc. Corporation Information
11.1.2 Acceleron Pharma, Inc. Description and Business Overview
11.1.3 Acceleron Pharma, Inc. Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Acceleron Pharma, Inc. Growth/Differentiation Factor 8 Products Offered
11.1.5 Acceleron Pharma, Inc. Related Developments
11.2 Atara Biotherapeutics, Inc.
11.2.1 Atara Biotherapeutics, Inc. Corporation Information
11.2.2 Atara Biotherapeutics, Inc. Description and Business Overview
11.2.3 Atara Biotherapeutics, Inc. Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Atara Biotherapeutics, Inc. Growth/Differentiation Factor 8 Products Offered
11.2.5 Atara Biotherapeutics, Inc. Related Developments
11.3 Bristol-Myers Squibb Company
11.3.1 Bristol-Myers Squibb Company Corporation Information
11.3.2 Bristol-Myers Squibb Company Description and Business Overview
11.3.3 Bristol-Myers Squibb Company Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Bristol-Myers Squibb Company Growth/Differentiation Factor 8 Products Offered
11.3.5 Bristol-Myers Squibb Company Related Developments
11.4 Eli Lilly and Company
11.4.1 Eli Lilly and Company Corporation Information
11.4.2 Eli Lilly and Company Description and Business Overview
11.4.3 Eli Lilly and Company Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Eli Lilly and Company Growth/Differentiation Factor 8 Products Offered
11.4.5 Eli Lilly and Company Related Developments
11.5 Milo Biotechnology LLC
11.5.1 Milo Biotechnology LLC Corporation Information
11.5.2 Milo Biotechnology LLC Description and Business Overview
11.5.3 Milo Biotechnology LLC Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Milo Biotechnology LLC Growth/Differentiation Factor 8 Products Offered
11.5.5 Milo Biotechnology LLC Related Developments
11.6 Pfizer Inc.
11.6.1 Pfizer Inc. Corporation Information
11.6.2 Pfizer Inc. Description and Business Overview
11.6.3 Pfizer Inc. Sales, Revenue and Gross Margin (2015-2020)
11.6.4 Pfizer Inc. Growth/Differentiation Factor 8 Products Offered
11.6.5 Pfizer Inc. Related Developments
11.7 Regeneron Pharmaceuticals, Inc.
11.7.1 Regeneron Pharmaceuticals, Inc. Corporation Information
11.7.2 Regeneron Pharmaceuticals, Inc. Description and Business Overview
11.7.3 Regeneron Pharmaceuticals, Inc. Sales, Revenue and Gross Margin (2015-2020)
11.7.4 Regeneron Pharmaceuticals, Inc. Growth/Differentiation Factor 8 Products Offered
11.7.5 Regeneron Pharmaceuticals, Inc. Related Developments
11.8 Sarepta Therapeutics, Inc.
11.8.1 Sarepta Therapeutics, Inc. Corporation Information
11.8.2 Sarepta Therapeutics, Inc. Description and Business Overview
11.8.3 Sarepta Therapeutics, Inc. Sales, Revenue and Gross Margin (2015-2020)
11.8.4 Sarepta Therapeutics, Inc. Growth/Differentiation Factor 8 Products Offered
11.8.5 Sarepta Therapeutics, Inc. Related Developments
11.9 Scholar Rock, Inc.
11.9.1 Scholar Rock, Inc. Corporation Information
11.9.2 Scholar Rock, Inc. Description and Business Overview
11.9.3 Scholar Rock, Inc. Sales, Revenue and Gross Margin (2015-2020)
11.9.4 Scholar Rock, Inc. Growth/Differentiation Factor 8 Products Offered
11.9.5 Scholar Rock, Inc. Related Developments
11.1 Acceleron Pharma, Inc.
11.1.1 Acceleron Pharma, Inc. Corporation Information
11.1.2 Acceleron Pharma, Inc. Description and Business Overview
11.1.3 Acceleron Pharma, Inc. Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Acceleron Pharma, Inc. Growth/Differentiation Factor 8 Products Offered
11.1.5 Acceleron Pharma, Inc. Related Developments
12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Growth/Differentiation Factor 8 Market Estimates and Projections by Region
12.1.1 Global Growth/Differentiation Factor 8 Sales Forecast by Regions 2021-2026
12.1.2 Global Growth/Differentiation Factor 8 Revenue Forecast by Regions 2021-2026
12.2 North America Growth/Differentiation Factor 8 Market Size Forecast (2021-2026)
12.2.1 North America: Growth/Differentiation Factor 8 Sales Forecast (2021-2026)
12.2.2 North America: Growth/Differentiation Factor 8 Revenue Forecast (2021-2026)
12.2.3 North America: Growth/Differentiation Factor 8 Market Size Forecast by Country (2021-2026)
12.3 Europe Growth/Differentiation Factor 8 Market Size Forecast (2021-2026)
12.3.1 Europe: Growth/Differentiation Factor 8 Sales Forecast (2021-2026)
12.3.2 Europe: Growth/Differentiation Factor 8 Revenue Forecast (2021-2026)
12.3.3 Europe: Growth/Differentiation Factor 8 Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Growth/Differentiation Factor 8 Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Growth/Differentiation Factor 8 Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Growth/Differentiation Factor 8 Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Growth/Differentiation Factor 8 Market Size Forecast by Region (2021-2026)
12.5 Latin America Growth/Differentiation Factor 8 Market Size Forecast (2021-2026)
12.5.1 Latin America: Growth/Differentiation Factor 8 Sales Forecast (2021-2026)
12.5.2 Latin America: Growth/Differentiation Factor 8 Revenue Forecast (2021-2026)
12.5.3 Latin America: Growth/Differentiation Factor 8 Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Growth/Differentiation Factor 8 Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Growth/Differentiation Factor 8 Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Growth/Differentiation Factor 8 Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Growth/Differentiation Factor 8 Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Growth/Differentiation Factor 8 Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Growth/Differentiation Factor 8 Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
Table 1. Growth/Differentiation Factor 8 Market Segments
Table 2. Ranking of Global Top Growth/Differentiation Factor 8 Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Growth/Differentiation Factor 8 Market Size Growth Rate by Type 2020-2026 (K Pcs) & (US$ Million)
Table 4. Major Manufacturers of OSX-200
Table 5. Major Manufacturers of SRK-015
Table 6. Major Manufacturers of ACE-2494
Table 7. Major Manufacturers of ACE-2798
Table 8. Major Manufacturers of BMS-986089
Table 9. Major Manufacturers of Others
Table 10. Global Growth/Differentiation Factor 8 Market Size Growth Rate by Application 2020-2026 (K Pcs)
Table 11. Global Growth/Differentiation Factor 8 Market Size by Region (K Pcs) & (US$ Million): 2020 VS 2026
Table 12. Global Growth/Differentiation Factor 8 Sales by Regions 2015-2020 (K Pcs)
Table 13. Global Growth/Differentiation Factor 8 Sales Market Share by Regions (2015-2020)
Table 14. Global Growth/Differentiation Factor 8 Revenue by Regions 2015-2020 (US$ Million)
Table 15. Global Growth/Differentiation Factor 8 Sales by Manufacturers (2015-2020) (K Pcs)
Table 16. Global Growth/Differentiation Factor 8 Sales Share by Manufacturers (2015-2020)
Table 17. Global Growth/Differentiation Factor 8 Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 18. Global Growth/Differentiation Factor 8 by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Growth/Differentiation Factor 8 as of 2019)
Table 19. Growth/Differentiation Factor 8 Revenue by Manufacturers (2015-2020) (US$ Million)
Table 20. Growth/Differentiation Factor 8 Revenue Share by Manufacturers (2015-2020)
Table 21. Key Manufacturers Growth/Differentiation Factor 8 Price (2015-2020) (USD/Pcs)
Table 22. Growth/Differentiation Factor 8 Manufacturers Manufacturing Base Distribution and Headquarters
Table 23. Manufacturers Growth/Differentiation Factor 8 Product Type
Table 24. Date of International Manufacturers Enter into Growth/Differentiation Factor 8 Market
Table 25. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 26. Global Growth/Differentiation Factor 8 Sales by Type (2015-2020) (K Pcs)
Table 27. Global Growth/Differentiation Factor 8 Sales Share by Type (2015-2020)
Table 28. Global Growth/Differentiation Factor 8 Revenue by Type (2015-2020) (US$ Million)
Table 29. Global Growth/Differentiation Factor 8 Revenue Share by Type (2015-2020)
Table 30. Growth/Differentiation Factor 8 Average Selling Price (ASP) by Type 2015-2020 (USD/Pcs)
Table 31. Global Growth/Differentiation Factor 8 Sales by Application (2015-2020) (K Pcs)
Table 32. Global Growth/Differentiation Factor 8 Sales Share by Application (2015-2020)
Table 33. North America Growth/Differentiation Factor 8 Sales by Country (2015-2020) (K Pcs)
Table 34. North America Growth/Differentiation Factor 8 Sales Market Share by Country (2015-2020)
Table 35. North America Growth/Differentiation Factor 8 Revenue by Country (2015-2020) (US$ Million)
Table 36. North America Growth/Differentiation Factor 8 Revenue Market Share by Country (2015-2020)
Table 37. North America Growth/Differentiation Factor 8 Sales by Type (2015-2020) (K Pcs)
Table 38. North America Growth/Differentiation Factor 8 Sales Market Share by Type (2015-2020)
Table 39. North America Growth/Differentiation Factor 8 Sales by Application (2015-2020) (K Pcs)
Table 40. North America Growth/Differentiation Factor 8 Sales Market Share by Application (2015-2020)
Table 41. Europe Growth/Differentiation Factor 8 Sales by Country (2015-2020) (K Pcs)
Table 42. Europe Growth/Differentiation Factor 8 Sales Market Share by Country (2015-2020)
Table 43. Europe Growth/Differentiation Factor 8 Revenue by Country (2015-2020) (US$ Million)
Table 44. Europe Growth/Differentiation Factor 8 Revenue Market Share by Country (2015-2020)
Table 45. Europe Growth/Differentiation Factor 8 Sales by Type (2015-2020) (K Pcs)
Table 46. Europe Growth/Differentiation Factor 8 Sales Market Share by Type (2015-2020)
Table 47. Europe Growth/Differentiation Factor 8 Sales by Application (2015-2020) (K Pcs)
Table 48. Europe Growth/Differentiation Factor 8 Sales Market Share by Application (2015-2020)
Table 49. Asia Pacific Growth/Differentiation Factor 8 Sales by Region (2015-2020) (K Pcs)
Table 50. Asia Pacific Growth/Differentiation Factor 8 Sales Market Share by Region (2015-2020)
Table 51. Asia Pacific Growth/Differentiation Factor 8 Revenue by Region (2015-2020) (US$ Million)
Table 52. Asia Pacific Growth/Differentiation Factor 8 Revenue Market Share by Region (2015-2020)
Table 53. Asia Pacific Growth/Differentiation Factor 8 Sales by Type (2015-2020) (K Pcs)
Table 54. Asia Pacific Growth/Differentiation Factor 8 Sales Market Share by Type (2015-2020)
Table 55. Asia Pacific Growth/Differentiation Factor 8 Sales by Application (2015-2020) (K Pcs)
Table 56. Asia Pacific Growth/Differentiation Factor 8 Sales Market Share by Application (2015-2020)
Table 57. Latin America Growth/Differentiation Factor 8 Sales by Country (2015-2020) (K Pcs)
Table 58. Latin America Growth/Differentiation Factor 8 Sales Market Share by Country (2015-2020)
Table 59. Latin Americaa Growth/Differentiation Factor 8 Revenue by Country (2015-2020) (US$ Million)
Table 60. Latin America Growth/Differentiation Factor 8 Revenue Market Share by Country (2015-2020)
Table 61. Latin America Growth/Differentiation Factor 8 Sales by Type (2015-2020) (K Pcs)
Table 62. Latin America Growth/Differentiation Factor 8 Sales Market Share by Type (2015-2020)
Table 63. Latin America Growth/Differentiation Factor 8 Sales by Application (2015-2020) (K Pcs)
Table 64. Latin America Growth/Differentiation Factor 8 Sales Market Share by Application (2015-2020)
Table 65. Middle East and Africa Growth/Differentiation Factor 8 Sales by Country (2015-2020) (K Pcs)
Table 66. Middle East and Africa Growth/Differentiation Factor 8 Sales Market Share by Country (2015-2020)
Table 67. Middle East and Africa Growth/Differentiation Factor 8 Revenue by Country (2015-2020) (US$ Million)
Table 68. Middle East and Africa Growth/Differentiation Factor 8 Revenue Market Share by Country (2015-2020)
Table 69. Middle East and Africa Growth/Differentiation Factor 8 Sales by Type (2015-2020) (K Pcs)
Table 70. Middle East and Africa Growth/Differentiation Factor 8 Sales Market Share by Type (2015-2020)
Table 71. Middle East and Africa Growth/Differentiation Factor 8 Sales by Application (2015-2020) (K Pcs)
Table 72. Middle East and Africa Growth/Differentiation Factor 8 Sales Market Share by Application (2015-2020)
Table 73. Acceleron Pharma, Inc. Corporation Information
Table 74. Acceleron Pharma, Inc. Description and Major Businesses
Table 75. Acceleron Pharma, Inc. Growth/Differentiation Factor 8 Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 76. Acceleron Pharma, Inc. Product
Table 77. Acceleron Pharma, Inc. Recent Development
Table 78. Atara Biotherapeutics, Inc. Corporation Information
Table 79. Atara Biotherapeutics, Inc. Description and Major Businesses
Table 80. Atara Biotherapeutics, Inc. Growth/Differentiation Factor 8 Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 81. Atara Biotherapeutics, Inc. Product
Table 82. Atara Biotherapeutics, Inc. Recent Development
Table 83. Bristol-Myers Squibb Company Corporation Information
Table 84. Bristol-Myers Squibb Company Description and Major Businesses
Table 85. Bristol-Myers Squibb Company Growth/Differentiation Factor 8 Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 86. Bristol-Myers Squibb Company Product
Table 87. Bristol-Myers Squibb Company Recent Development
Table 88. Eli Lilly and Company Corporation Information
Table 89. Eli Lilly and Company Description and Major Businesses
Table 90. Eli Lilly and Company Growth/Differentiation Factor 8 Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 91. Eli Lilly and Company Product
Table 92. Eli Lilly and Company Recent Development
Table 93. Milo Biotechnology LLC Corporation Information
Table 94. Milo Biotechnology LLC Description and Major Businesses
Table 95. Milo Biotechnology LLC Growth/Differentiation Factor 8 Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 96. Milo Biotechnology LLC Product
Table 97. Milo Biotechnology LLC Recent Development
Table 98. Pfizer Inc. Corporation Information
Table 99. Pfizer Inc. Description and Major Businesses
Table 100. Pfizer Inc. Growth/Differentiation Factor 8 Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 101. Pfizer Inc. Product
Table 102. Pfizer Inc. Recent Development
Table 103. Regeneron Pharmaceuticals, Inc. Corporation Information
Table 104. Regeneron Pharmaceuticals, Inc. Description and Major Businesses
Table 105. Regeneron Pharmaceuticals, Inc. Growth/Differentiation Factor 8 Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 106. Regeneron Pharmaceuticals, Inc. Product
Table 107. Regeneron Pharmaceuticals, Inc. Recent Development
Table 108. Sarepta Therapeutics, Inc. Corporation Information
Table 109. Sarepta Therapeutics, Inc. Description and Major Businesses
Table 110. Sarepta Therapeutics, Inc. Growth/Differentiation Factor 8 Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 111. Sarepta Therapeutics, Inc. Product
Table 112. Sarepta Therapeutics, Inc. Recent Development
Table 113. Scholar Rock, Inc. Corporation Information
Table 114. Scholar Rock, Inc. Description and Major Businesses
Table 115. Scholar Rock, Inc. Growth/Differentiation Factor 8 Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 116. Scholar Rock, Inc. Product
Table 117. Scholar Rock, Inc. Recent Development
Table 118. Global Growth/Differentiation Factor 8 Sales Forecast by Regions (2021-2026) (K Pcs)
Table 119. Global Growth/Differentiation Factor 8 Sales Market Share Forecast by Regions (2021-2026)
Table 120. Global Growth/Differentiation Factor 8 Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 121. Global Growth/Differentiation Factor 8 Revenue Market Share Forecast by Regions (2021-2026)
Table 122. North America: Growth/Differentiation Factor 8 Sales Forecast by Country (2021-2026) (K Pcs)
Table 123. North America: Growth/Differentiation Factor 8 Revenue Forecast by Country (2021-2026) (US$ Million)
Table 124. Europe: Growth/Differentiation Factor 8 Sales Forecast by Country (2021-2026) (K Pcs)
Table 125. Europe: Growth/Differentiation Factor 8 Revenue Forecast by Country (2021-2026) (US$ Million)
Table 126. Asia Pacific: Growth/Differentiation Factor 8 Sales Forecast by Region (2021-2026) (K Pcs)
Table 127. Asia Pacific: Growth/Differentiation Factor 8 Revenue Forecast by Region (2021-2026) (US$ Million)
Table 128. Latin America: Growth/Differentiation Factor 8 Sales Forecast by Country (2021-2026) (K Pcs)
Table 129. Latin America: Growth/Differentiation Factor 8 Revenue Forecast by Country (2021-2026) (US$ Million)
Table 130. Middle East and Africa: Growth/Differentiation Factor 8 Sales Forecast by Country (2021-2026) (K Pcs)
Table 131. Middle East and Africa: Growth/Differentiation Factor 8 Revenue Forecast by Country (2021-2026) (US$ Million)
Table 132. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 133. Key Challenges
Table 134. Market Risks
Table 135. Main Points Interviewed from Key Growth/Differentiation Factor 8 Players
Table 136. Growth/Differentiation Factor 8 Customers List
Table 137. Growth/Differentiation Factor 8 Distributors List
Table 138. Research Programs/Design for This Report
Table 139. Key Data Information from Secondary Sources
Table 140. Key Data Information from Primary Sources
List of Figures
Figure 1. Growth/Differentiation Factor 8 Product Picture
Figure 2. Global Growth/Differentiation Factor 8 Sales Market Share by Type in 2020 & 2026
Figure 3. OSX-200 Product Picture
Figure 4. SRK-015 Product Picture
Figure 5. ACE-2494 Product Picture
Figure 6. ACE-2798 Product Picture
Figure 7. BMS-986089 Product Picture
Figure 8. Others Product Picture
Figure 9. Global Growth/Differentiation Factor 8 Sales Market Share by Application in 2020 & 2026
Figure 10. Becker Muscular Dystrophy
Figure 11. Fibrosis
Figure 12. Myelofibrosis
Figure 13. Sickle Cell Disease
Figure 14. Others
Figure 15. Growth/Differentiation Factor 8 Report Years Considered
Figure 16. Global Growth/Differentiation Factor 8 Market Size 2015-2026 (US$ Million)
Figure 17. Global Growth/Differentiation Factor 8 Sales 2015-2026 (K Pcs)
Figure 18. Global Growth/Differentiation Factor 8 Market Size Market Share by Region: 2020 Versus 2026
Figure 19. Global Growth/Differentiation Factor 8 Sales Market Share by Region (2015-2020)
Figure 20. Global Growth/Differentiation Factor 8 Sales Market Share by Region in 2019
Figure 21. Global Growth/Differentiation Factor 8 Revenue Market Share by Region (2015-2020)
Figure 22. Global Growth/Differentiation Factor 8 Revenue Market Share by Region in 2019
Figure 23. Global Growth/Differentiation Factor 8 Sales Share by Manufacturer in 2019
Figure 24. The Top 10 and 5 Players Market Share by Growth/Differentiation Factor 8 Revenue in 2019
Figure 25. Growth/Differentiation Factor 8 Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 26. Global Growth/Differentiation Factor 8 Sales Market Share by Type (2015-2020)
Figure 27. Global Growth/Differentiation Factor 8 Sales Market Share by Type in 2019
Figure 28. Global Growth/Differentiation Factor 8 Revenue Market Share by Type (2015-2020)
Figure 29. Global Growth/Differentiation Factor 8 Revenue Market Share by Type in 2019
Figure 30. Global Growth/Differentiation Factor 8 Market Share by Price Range (2015-2020)
Figure 31. Global Growth/Differentiation Factor 8 Sales Market Share by Application (2015-2020)
Figure 32. Global Growth/Differentiation Factor 8 Sales Market Share by Application in 2019
Figure 33. Global Growth/Differentiation Factor 8 Revenue Market Share by Application (2015-2020)
Figure 34. Global Growth/Differentiation Factor 8 Revenue Market Share by Application in 2019
Figure 35. North America Growth/Differentiation Factor 8 Sales Growth Rate 2015-2020 (K Pcs)
Figure 36. North America Growth/Differentiation Factor 8 Revenue Growth Rate 2015-2020 (US$ Million)
Figure 37. North America Growth/Differentiation Factor 8 Sales Market Share by Country in 2019
Figure 38. North America Growth/Differentiation Factor 8 Revenue Market Share by Country in 2019
Figure 39. U.S. Growth/Differentiation Factor 8 Sales Growth Rate (2015-2020) (K Pcs)
Figure 40. U.S. Growth/Differentiation Factor 8 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 41. Canada Growth/Differentiation Factor 8 Sales Growth Rate (2015-2020) (K Pcs)
Figure 42. Canada Growth/Differentiation Factor 8 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 43. North America Growth/Differentiation Factor 8 Market Share by Type in 2019
Figure 44. North America Growth/Differentiation Factor 8 Market Share by Application in 2019
Figure 45. Europe Growth/Differentiation Factor 8 Sales Growth Rate 2015-2020 (K Pcs)
Figure 46. Europe Growth/Differentiation Factor 8 Revenue Growth Rate 2015-2020 (US$ Million)
Figure 47. Europe Growth/Differentiation Factor 8 Sales Market Share by Country in 2019
Figure 48. Europe Growth/Differentiation Factor 8 Revenue Market Share by Country in 2019
Figure 49. Germany Growth/Differentiation Factor 8 Sales Growth Rate (2015-2020) (K Pcs)
Figure 50. Germany Growth/Differentiation Factor 8 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 51. France Growth/Differentiation Factor 8 Sales Growth Rate (2015-2020) (K Pcs)
Figure 52. France Growth/Differentiation Factor 8 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 53. U.K. Growth/Differentiation Factor 8 Sales Growth Rate (2015-2020) (K Pcs)
Figure 54. U.K. Growth/Differentiation Factor 8 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 55. Italy Growth/Differentiation Factor 8 Sales Growth Rate (2015-2020) (K Pcs)
Figure 56. Italy Growth/Differentiation Factor 8 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 57. Russia Growth/Differentiation Factor 8 Sales Growth Rate (2015-2020) (K Pcs)
Figure 58. Russia Growth/Differentiation Factor 8 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 59. Europe Growth/Differentiation Factor 8 Market Share by Type in 2019
Figure 60. Europe Growth/Differentiation Factor 8 Market Share by Application in 2019
Figure 61. Asia Pacific Growth/Differentiation Factor 8 Sales Growth Rate 2015-2020 (K Pcs)
Figure 62. Asia Pacific Growth/Differentiation Factor 8 Revenue Growth Rate 2015-2020 (US$ Million)
Figure 63. Asia Pacific Growth/Differentiation Factor 8 Sales Market Share by Region in 2019
Figure 64. Asia Pacific Growth/Differentiation Factor 8 Revenue Market Share by Region in 2019
Figure 65. China Growth/Differentiation Factor 8 Sales Growth Rate (2015-2020) (K Pcs)
Figure 66. China Growth/Differentiation Factor 8 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 67. Japan Growth/Differentiation Factor 8 Sales Growth Rate (2015-2020) (K Pcs)
Figure 68. Japan Growth/Differentiation Factor 8 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 69. South Korea Growth/Differentiation Factor 8 Sales Growth Rate (2015-2020) (K Pcs)
Figure 70. South Korea Growth/Differentiation Factor 8 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 71. India Growth/Differentiation Factor 8 Sales Growth Rate (2015-2020) (K Pcs)
Figure 72. India Growth/Differentiation Factor 8 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 73. Australia Growth/Differentiation Factor 8 Sales Growth Rate (2015-2020) (K Pcs)
Figure 74. Australia Growth/Differentiation Factor 8 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 75. Taiwan Growth/Differentiation Factor 8 Sales Growth Rate (2015-2020) (K Pcs)
Figure 76. Taiwan Growth/Differentiation Factor 8 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 77. Indonesia Growth/Differentiation Factor 8 Sales Growth Rate (2015-2020) (K Pcs)
Figure 78. Indonesia Growth/Differentiation Factor 8 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 79. Thailand Growth/Differentiation Factor 8 Sales Growth Rate (2015-2020) (K Pcs)
Figure 80. Thailand Growth/Differentiation Factor 8 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 81. Malaysia Growth/Differentiation Factor 8 Sales Growth Rate (2015-2020) (K Pcs)
Figure 82. Malaysia Growth/Differentiation Factor 8 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 83. Philippines Growth/Differentiation Factor 8 Sales Growth Rate (2015-2020) (K Pcs)
Figure 84. Philippines Growth/Differentiation Factor 8 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 85. Vietnam Growth/Differentiation Factor 8 Sales Growth Rate (2015-2020) (K Pcs)
Figure 86. Vietnam Growth/Differentiation Factor 8 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 87. Asia Pacific Growth/Differentiation Factor 8 Market Share by Type in 2019
Figure 88. Asia Pacific Growth/Differentiation Factor 8 Market Share by Application in 2019
Figure 89. Latin America Growth/Differentiation Factor 8 Sales Growth Rate 2015-2020 (K Pcs)
Figure 90. Latin America Growth/Differentiation Factor 8 Revenue Growth Rate 2015-2020 (US$ Million)
Figure 91. Latin America Growth/Differentiation Factor 8 Sales Market Share by Country in 2019
Figure 92. Latin America Growth/Differentiation Factor 8 Revenue Market Share by Country in 2019
Figure 93. Mexico Growth/Differentiation Factor 8 Sales Growth Rate (2015-2020) (K Pcs)
Figure 94. Mexico Growth/Differentiation Factor 8 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 95. Brazil Growth/Differentiation Factor 8 Sales Growth Rate (2015-2020) (K Pcs)
Figure 96. Brazil Growth/Differentiation Factor 8 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 97. Argentina Growth/Differentiation Factor 8 Sales Growth Rate (2015-2020) (K Pcs)
Figure 98. Argentina Growth/Differentiation Factor 8 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 99. Latin America Growth/Differentiation Factor 8 Market Share by Type in 2019
Figure 100. Latin America Growth/Differentiation Factor 8 Market Share by Application in 2019
Figure 101. Middle East and Africa Growth/Differentiation Factor 8 Sales Growth Rate 2015-2020 (K Pcs)
Figure 102. Middle East and Africa Growth/Differentiation Factor 8 Revenue Growth Rate 2015-2020 (US$ Million)
Figure 103. Middle East and Africa Growth/Differentiation Factor 8 Sales Market Share by Country in 2019
Figure 104. Middle East and Africa Growth/Differentiation Factor 8 Revenue Market Share by Country in 2019
Figure 105. Turkey Growth/Differentiation Factor 8 Sales Growth Rate (2015-2020) (K Pcs)
Figure 106. Turkey Growth/Differentiation Factor 8 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 107. Saudi Arabia Growth/Differentiation Factor 8 Sales Growth Rate (2015-2020) (K Pcs)
Figure 108. Saudi Arabia Growth/Differentiation Factor 8 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 109. U.A.E Growth/Differentiation Factor 8 Sales Growth Rate (2015-2020) (K Pcs)
Figure 110. U.A.E Growth/Differentiation Factor 8 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 111. Middle East and Africa Growth/Differentiation Factor 8 Market Share by Type in 2019
Figure 112. Middle East and Africa Growth/Differentiation Factor 8 Market Share by Application in 2019
Figure 113. North America Growth/Differentiation Factor 8 Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 114. North America Growth/Differentiation Factor 8 Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 115. Europe Growth/Differentiation Factor 8 Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 116. Europe Growth/Differentiation Factor 8 Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 117. Asia Pacific Growth/Differentiation Factor 8 Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 118. Asia Pacific Growth/Differentiation Factor 8 Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 119. Latin America Growth/Differentiation Factor 8 Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 120. Latin America Growth/Differentiation Factor 8 Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 121. Middle East and Africa Growth/Differentiation Factor 8 Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 122. Middle East and Africa Growth/Differentiation Factor 8 Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 123. Porter's Five Forces Analysis
Figure 124. Channels of Distribution
Figure 125. Distributors Profiles
Figure 126. Bottom-up and Top-down Approaches for This Report
Figure 127. Data Triangulation
Figure 128. Key Executives Interviewed
第IX因子欠乏症治療の世界市場（～2026年） Factor IX (or Christmas factor) is one of the serine proteases of the coagulation system; it belongs to peptidase family S1. Deficiency of this protein causes hemophilia B. In this market study, analysts have estimated the prophylaxis segment to dominate the factor IX deficiency treatment market dur…- インシュリン様成長因子Iの世界市場（～2026年） Market Analysis and Insights: Global Insulin Like Growth Factor I Market The global Insulin Like Growth Factor I market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Insulin Like Growth Factor I Scope and Market Size Insuli…
- 血友病A・B組換え因子補充療法の世界市場（～2026年） Haemophilia is a group of inherited genetic disorders which causes abnormal or exaggerated bleeding. It impairs the normal mechanism of blood clotting after an injury. Internal bleeding inside the joint or inside brain is commonly seen in the patients with severe to moderate haemophilia. Its symptom…
- 線維芽細胞成長因子2の世界市場（～2026年） Market Analysis and Insights: Global Fibroblast Growth Factor 2 Market The global Fibroblast Growth Factor 2 market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Fibroblast Growth Factor 2 Scope and Market Size Fibroblast G…
- 力率補正装置の世界市場（～2026年） Power-factor correction increases the power factor of a load, improving efficiency for the distribution system to which it is attached. Linear loads with low power factor (such as induction motors) can be corrected with a passive network of capacitors or inductors. Non-linear loads, such as rectifie…